Latest Articles

Publication Date
All News Scientific
Construction of cuproptosis-related genes risk model predicts the prognosis of Uterine Corpus Endometrial Carcinoma - Nature.com

Construction of cuproptosis-related genes risk model predicts the prognosis of Uterine Corpus Endometrial Carcinoma Nature.com

Published: Jan. 17, 2025, 8:46 a.m.
Read Full Article
A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma - Nature.com

A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma Nature.com

Published: Jan. 9, 2025, 7:28 a.m.
Read Full Article
A risk prediction model for endometrial hyperplasia/endometrial carcinoma in premenopausal women - Nature.com

A risk prediction model for endometrial hyperplasia/endometrial carcinoma in premenopausal women Nature.com

Published: Jan. 6, 2025, 7:05 p.m.
Read Full Article
Bioinformatics approaches to multi-omics analysis of the potential of CDKN2A as a biomarker and therapeutic target for uterine corpus endometrial carcinoma - Nature.com

Bioinformatics approaches to multi-omics analysis of the potential of CDKN2A as a biomarker and therapeutic target for uterine corpus endometrial carcinoma Nature.com

Published: Jan. 6, 2025, 7:50 a.m.
Read Full Article
Exploratory Analysis of Radiomics and Pathomics in Uterine Corpus Endometrial Carcinoma - Nature.com

Exploratory Analysis of Radiomics and Pathomics in Uterine Corpus Endometrial Carcinoma Nature.com

Published: Dec. 28, 2024, 3:08 a.m.
Read Full Article
TEFM facilitates uterine corpus endometrial carcinoma progression by activating ROS-NFκB pathway - Journal of Translational Medicine

TEFM facilitates uterine corpus endometrial carcinoma progression by activating ROS-NFκB pathway Journal of Translational Medicine

Published: Dec. 27, 2024, 1:02 p.m.
Read Full Article
HLA-DMB Correlates With Antitumor Immunity and an Improved Prognosis in Endometrial Carcinoma Tumors - Frontiers

HLA-DMB Correlates With Antitumor Immunity and an Improved Prognosis in Endometrial Carcinoma Tumors Frontiers

Published: Dec. 20, 2024, 4:13 p.m.
Read Full Article
MTFR2 promotes endometrial carcinoma cell proliferation and growth via the miR-132-3p /PI3K/Akt signaling pathway - Frontiers

MTFR2 promotes endometrial carcinoma cell proliferation and growth via the miR-132-3p /PI3K/Akt signaling pathway Frontiers

Published: Nov. 25, 2024, 3:55 p.m.
Read Full Article
A Case of Early-Stage Lower Uterine Segment Carcinoma With Hysteroscopic Observation of Visual Changes Induced by a Gonadotropin-Releasing Hormone (GnRH) Antagonist - Cureus

A Case of Early-Stage Lower Uterine Segment Carcinoma With Hysteroscopic Observation of Visual Changes Induced by a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cureus

Published: Nov. 23, 2024, 11:41 a.m.
Read Full Article
Undifferentiated Endometrial Carcinoma Occurred During Perimenopausal Hormone Therapy: A Case Report and Literature Review - Frontiers

Undifferentiated Endometrial Carcinoma Occurred During Perimenopausal Hormone Therapy: A Case Report and Literature Review Frontiers

Published: Oct. 18, 2024, 10:58 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!